A Korean manufacturer of PNA (Peptide Nucleic Acid) technology-based mutation detection kits and oncology molecular diagnostic kits is seeking distribution opportunities to expand its market abroad
A Korean SME has managed to dominate the domestic market since 2012 by covering a majority market share of oncology molecular diagnostic and mutation detection parts with its cutting-edge platform technology based on PNA, Peptide Nucleic Acid. The company is seeking distributors or manufacturers capable of conducting promotion and sales for the products under a distribution service agreement.